Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan

Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan

Item
http://www.wikidata.org/entity/Q28345820
Compartmentalized accumulation of cAMP near complexes of multidrug resistance protein 4 (MRP4) and cystic fibrosis transmembrane conductance regulator (CFTR) contributes to drug-induced diarrhea.Comment on a published paper. The adverse cholinergic effects of the chemotherapeutic agent irinotecan (CPT-11) were unlikely to be mediated by the inhibition of acetylcholinesterase (AChE)Application of a combination of a knowledge-based algorithm and 2-stage screening to hypothesis-free genomic data on irinotecan-treated patients for identification of a candidate single nucleotide polymorphism related to an adverse effectPhase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patientsRole of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice.Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.Irinotecan-induced dysarthria: an insight into its pathogenesis?Reply to Dodds & Rivory.
P2860

Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan

Item
http://www.wikidata.org/entity/Q28345820
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Characterization of a novel me ...... the anticancer drug irinotecan
@ast
Characterization of a novel me ...... the anticancer drug irinotecan
@en
Characterization of a novel me ...... the anticancer drug irinotecan
@nl
type
label
Characterization of a novel me ...... the anticancer drug irinotecan
@ast
Characterization of a novel me ...... the anticancer drug irinotecan
@en
Characterization of a novel me ...... the anticancer drug irinotecan
@nl
prefLabel
Characterization of a novel me ...... the anticancer drug irinotecan
@ast
Characterization of a novel me ...... the anticancer drug irinotecan
@en
Characterization of a novel me ...... the anticancer drug irinotecan
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Characterization of a novel me ...... the anticancer drug irinotecan
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932